|
7 Companies |
|
7 Products |
|
7 Products |
|
7 Mechanisms of Action |
|
0 Trials |
|
36 News |
|
- | sirolimus / Generic mfg.
Trial termination, Immune cell: Donor Stem Cell Transplant With No or Low-Intensity Chemotherapy Using Sirolimus and Treated Immune Cells to Treat Blood and Lymph Cancers (clinicaltrials.gov) - Dec 31, 2018
P2, N=442, Terminated, Sponsor: National Cancer Institute (NCI)
Completed --> Terminated; Premature closure due to inability to accrue to ARM IVD, cohorts 1 and 2
- | Trial completion: Clinical Trial of a Serious Game for Individuals With SCI/D (clinicaltrials.gov) - Oct 17, 2017
P=N/A, N=178, Completed, Sponsor: University of Michigan
Completed --> Terminated; Premature closure due to inability to accrue to ARM IVD, cohorts 1 and 2 Active, not recruiting --> Completed
- | sirolimus / Generic mfg.
Trial completion, Trial primary completion date, Immune cell: Donor Stem Cell Transplant With No or Low-Intensity Chemotherapy Using Sirolimus and Treated Immune Cells to Treat Blood and Lymph Cancers (clinicaltrials.gov) - Aug 18, 2017
P2, N=380, Completed, Sponsor: National Cancer Institute (NCI)
Active, not recruiting --> Completed Active, not recruiting --> Completed | Trial primary completion date: Dec 2021 --> Aug 2017
- | Enrollment closed, Phase classification, Trial primary completion date: Clinical Trial of a Serious Game for Individuals With SCI/D (clinicaltrials.gov) - May 17, 2017
P=N/A, N=178, Active, not recruiting, Sponsor: University of Michigan
Active, not recruiting --> Completed | Trial primary completion date: Dec 2021 --> Aug 2017 Recruiting --> Active, not recruiting | Phase classification: P3 --> PN/A | Trial primary completion date: Sep 2018 --> Sep 2017
- | Trial completion: Outcome of Fetal Spina Bifida (clinicaltrials.gov) - Mar 14, 2017
P=N/A, N=103, Completed, Sponsor: University of Luebeck
Recruiting --> Active, not recruiting | Phase classification: P3 --> PN/A | Trial primary completion date: Sep 2018 --> Sep 2017 Recruiting --> Completed
- Trial primary completion date: Clinical Trial of a Serious Game for Individuals With SCI/D (clinicaltrials.gov) - Oct 25, 2016
P3, N=200, Recruiting, Sponsor: University of Michigan
Recruiting --> Completed Trial primary completion date: Apr 2016 --> Sep 2018
- sirolimus / Generic mfg.
Enrollment closed, Enrollment change, Immune cell: Donor Stem Cell Transplant With No or Low-Intensity Chemotherapy Using Sirolimus and Treated Immune Cells to Treat Blood and Lymph Cancers (clinicaltrials.gov) - Sep 26, 2016
P2, N=377, Active, not recruiting, Sponsor: National Cancer Institute (NCI)
Trial primary completion date: Apr 2016 --> Sep 2018 Recruiting --> Active, not recruiting | N=510 --> 377
- ethinyl estradiol/norgestimate / Generic mfg.
Enrollment change: A Study to Evaluate Folate Levels in Women Taking Oral Contraceptives (clinicaltrials.gov) - Sep 20, 2016
P3, N=0, Withdrawn, Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Recruiting --> Active, not recruiting | N=510 --> 377 N=300 --> 0
- Trial primary completion date: Clinical Trial of a Serious Game for Individuals With SCI/D (clinicaltrials.gov) - Jan 17, 2016
P3, N=200, Recruiting, Sponsor: University of Michigan
N=300 --> 0 Trial primary completion date: Dec 2015 --> Apr 2016
- Trial completion: UGAFOLATEPILOT: Folate Metabolism in Normal Weight and Obese Women of Child-bearing Age (clinicaltrials.gov) - Oct 21, 2015
P=N/A, N=32, Completed, Sponsor: University of Georgia
Trial primary completion date: Dec 2015 --> Apr 2016 Active, not recruiting --> Completed
- sirolimus / Generic mfg.
Enrollment open, Enrollment change, Immune cell: Donor Stem Cell Transplant With No or Low-Intensity Chemotherapy Using Sirolimus and Treated Immune Cells to Treat Blood and Lymph Cancers (clinicaltrials.gov) - Sep 29, 2015
P2, N=510, Recruiting, Sponsor: National Cancer Institute (NCI)
Active, not recruiting --> Completed Suspended --> Recruiting | N=352 --> 510
- Enrollment change: Probiotics in Girls With Spina Bifida (clinicaltrials.gov) - Sep 16, 2015
P2, N=0, Withdrawn, Sponsor: Baylor College of Medicine
Suspended --> Recruiting | N=352 --> 510 N=60 --> 0
- sirolimus / Generic mfg.
Enrollment change, Trial suspension, Immune cell: Donor Stem Cell Transplant With No or Low-Intensity Chemotherapy Using Sirolimus and Treated Immune Cells to Treat Blood and Lymph Cancers (clinicaltrials.gov) - Aug 21, 2015
P2, N=336, Suspended, Sponsor: National Cancer Institute (NCI)
N=60 --> 0 N=510 --> 336 | Recruiting --> Suspended
- Trial completion: Prevention of Neural Tube Defects by Inositol in Conjunction With Folic Acid (PONTI Study) (clinicaltrials.gov) - Jun 23, 2015
P1, N=100, Completed, Sponsor: Institute of Child Health
N=510 --> 336 | Recruiting --> Suspended Recruiting --> Completed
- Trial completion: Lumbar to Sacral Ventral Nerve Re-Routing (clinicaltrials.gov) - Feb 6, 2015
P2, N=13, Completed, Sponsor: Kenneth Peters, MD
Recruiting --> Completed Active, not recruiting --> Completed
- || New P3 trial: Clinical Trial of a Serious Game for Individuals With SCI/D (clinicaltrials.gov) - Jan 20, 2015
P3, N=200, Recruiting, Sponsor: University of Michigan
- sirolimus / Generic mfg.
Trial primary completion date, Immune cell: Donor Stem Cell Transplant With No or Low-Intensity Chemotherapy Using Sirolimus and Treated Immune Cells to Treat Blood and Lymph Cancers (clinicaltrials.gov) - Sep 10, 2014
P2, N=510, Recruiting, Sponsor: National Cancer Institute (NCI)
Active, not recruiting --> Completed Trial primary completion date: Jun 2015 --> Dec 2021
- Trial primary completion date: Lumbar to Sacral Ventral Nerve Re-Routing (clinicaltrials.gov) - May 11, 2014
P2, N=12, Active, not recruiting, Sponsor: Kenneth Peters, MD
Trial primary completion date: Jun 2015 --> Dec 2021 Trial primary completion date: Jun 2014 --> Dec 2014
- Trial completion date: Lumbar to Sacral Ventral Nerve Re-Routing (clinicaltrials.gov) - May 11, 2014
P2, N=12, Active, not recruiting, Sponsor: Kenneth Peters, MD
Trial primary completion date: Jun 2014 --> Dec 2014 Trial completion date: Jun 2014 --> Dec 2014
- Trial completion: Cognitive Rehabilitation in Patients With Spina Bifida (clinicaltrials.gov) - Jan 20, 2014
P=N/A, N=38, Completed, Sponsor: Jan Stubberud
Trial completion date: Jun 2014 --> Dec 2014 Active, not recruiting --> Completed
- Trial withdrawal: Nerve Rerouting Treatment for Neurogenic Bladder in Spina Bifida (clinicaltrials.gov) - Jul 30, 2013
P=N/A, N=0, Withdrawn, Sponsor: Kenneth Peters, MD
Active, not recruiting --> Completed Not yet recruiting --> Withdrawn
- Enrollment change: Nerve Rerouting Treatment for Neurogenic Bladder in Spina Bifida (clinicaltrials.gov) - Jul 30, 2013
P=N/A, N=0, Withdrawn, Sponsor: Kenneth Peters, MD
Not yet recruiting --> Withdrawn N=16 --> 0
- Enrollment change: Comparing Urinary Tract Infections in Children With Spina Bifida Using Two Types of Catheters for Catheterization (clinicaltrials.gov) - Jun 18, 2013
P=N/A, N=46, Completed, Sponsor: University of Alberta
N=16 --> 0 N=97 --> 46
- Trial completion: Comparing Urinary Tract Infections in Children With Spina Bifida Using Two Types of Catheters for Catheterization (clinicaltrials.gov) - Jun 18, 2013
P=N/A, N=46, Completed, Sponsor: University of Alberta
N=97 --> 46 Active, not recruiting --> Completed
- Clinical: UGAFOLATEPILOT: Folate Metabolism in Normal Weight and Obese Women of Child-bearing Age (clinicaltrials.gov) - Dec 4, 2012
P=N/A, N=32, Active, not recruiting, Sponsor: University of Georgia
- Enrollment change: A Randomized Exercise Trial for Wheelchair Users (clinicaltrials.gov) - Jun 12, 2012
P=N/A, N=135, Completed, Sponsor: University of Kansas
Active, not recruiting --> Completed N=180 --> 135
- Trial completion: A Randomized Exercise Trial for Wheelchair Users (clinicaltrials.gov) - Jun 12, 2012
P=N/A, N=135, Completed, Sponsor: University of Kansas
N=180 --> 135 Active, not recruiting --> Completed
- Trial completion: Efficacy of Weekly Versus Daily Folic Acid Supplementation (clinicaltrials.gov) - Mar 28, 2012
P=N/A, N=460, Completed, Sponsor: Emory University
Active, not recruiting --> Completed Active, not recruiting --> Completed
- pamidronate disodium / Generic mfg.
Trial completion: Prevention of Post Operative Bone Loss in Children (clinicaltrials.gov) - Feb 28, 2012
P=N/A, N=24, Completed, Sponsor: University of New Mexico
Active, not recruiting --> Completed Recruiting --> Completed
- Enrollment change: Coping Skills Training (CST) for Children With Chronic Health Conditions (clinicaltrials.gov) - Feb 15, 2012
P2, N=38, Completed, Sponsor: Children's Hospital and Health System Foundation, Wisconsin
Recruiting --> Completed N=50 --> 38
- Trial completion: Coping Skills Training (CST) for Children With Chronic Health Conditions (clinicaltrials.gov) - Feb 15, 2012
P2, N=38, Completed, Sponsor: Children's Hospital and Health System Foundation, Wisconsin
N=50 --> 38 Recruiting --> Completed
- Trial completion: Influence of "Espresso" on Adsorption of Myo-inositol (clinicaltrials.gov) - Jan 10, 2012
P=N/A, N=12, Completed, Sponsor: AGUNCO Obstetrics and Gynecology Centre
Recruiting --> Completed Recruiting --> Completed
- Trial termination: Yulex Glove Prospective Study in Spina Bifida (clinicaltrials.gov) - Dec 21, 2011
P=N/A, N=7, Terminated, Sponsor: Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
Recruiting --> Completed Recruiting --> Terminated; The funder never paid for the study.
- Enrollment change: Yulex Glove Prospective Study in Spina Bifida (clinicaltrials.gov) - Dec 21, 2011
P=N/A, N=7, Terminated, Sponsor: Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
Recruiting --> Terminated; The funder never paid for the study. N=50 --> 7
- metformin / Generic mfg.
Trial completion: Metformin in Children With Motor Deficit (clinicaltrials.gov) - Sep 27, 2011
P=N/A, N=42, Completed, Sponsor: Universitaire Ziekenhuizen Leuven
N=50 --> 7 Active, not recruiting --> Completed
- Neo-Bladder Augment / RegenMedTX
Trial termination: Augmentation Cystoplasty Using an Autologous Neo-Bladder (clinicaltrials.gov) - Aug 11, 2011
P2, N=10, Terminated, Sponsor: Tengion
Active, not recruiting --> Terminated; 36 months follow up without change to profile. No further studies planned.